Sino Biopharmaceutical (1177) Price & Analysis

Compare

14 Followers

1177 Stock Chart & Stats

Day’s Range― - ―

52-Week RangeHK$2.55 - HK$5.78

Previous CloseN/A

Volume63.93M

Average Volume (3M)156.12M

Market Cap

$89.24B

Enterprise ValueHK$84.65B

Total Cash (Recent Filing)$14.60B

Total Debt (Recent Filing)¥9.78B

Price to Earnings (P/E)47.0

Beta1.17

Next Earnings

Aug 28, 2025

EPS Estimate

0.09

Last Dividend Ex-Date

Jun 16, 2025

Dividend Yield12.58%

Share Statistics

EPS (TTM)0.03

Shares Outstanding18,760,717,000

10 Day Avg. Volume227,806,069

30 Day Avg. Volume156,115,587

Financial Highlights & Ratios

PEG Ratio1.17

Price to Book (P/B)2.54

Price to Sales (P/S)0.00

P/FCF Ratio31.58

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$6.04

Price Target Upside17.14% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Sino Biopharmaceutical News

PremiumCompany Announcements

Sino Biopharmaceutical Reports Breakthrough in GVHD Treatment with Rovadicitinib

6d ago

PremiumCompany Announcements

Sino Biopharmaceutical’s TDI01 Gains Breakthrough Therapy Designation

8d ago

PremiumCompany Announcements

Sino Biopharmaceutical Advances Innovation-Driven Strategy with New Product Launches

12d ago

PremiumCompany Announcements

Sino Biopharmaceutical Secures Shareholder Approval for Key Resolutions at AGM

14d ago

PremiumCompany Announcements

Sino Biopharmaceutical Advances Phase III Study for Promising Pancreatic Cancer Drug

14d ago

PremiumCompany Announcements

Sino Biopharmaceutical’s TQC3721 Receives Phase III Clinical Study Approval

15d ago

PremiumCompany Announcements

Sino Biopharmaceutical’s Breakthrough in NSCLC Treatment at 2025 ASCO Meeting

20d ago

PremiumCompany Announcements

Sino Biopharmaceutical’s Phase III Study Shows Promising Results for NSCLC Treatment

21d ago

See All HK:1177 News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

8.84% Insiders

2.54%

Mutual Funds

<0.01% Other Institutional Investors

83.20% Public Companies and

Individual Investors

Detailed Ownership Overview >

1177 FAQ

What was Sino Biopharmaceutical Ltd’s price range in the past 12 months?

Sino Biopharmaceutical Ltd lowest stock price was HK$2.55 and its highest was HK$5.78 in the past 12 months.

What is Sino Biopharmaceutical Ltd’s market cap?

Sino Biopharmaceutical Ltd’s market cap is $89.24B.

When is Sino Biopharmaceutical Ltd’s upcoming earnings report date?

Sino Biopharmaceutical Ltd’s upcoming earnings report date is Aug 28, 2025 which is in 65 days.

How were Sino Biopharmaceutical Ltd’s earnings last quarter?

Sino Biopharmaceutical Ltd released its earnings results on Mar 20, 2025. The company reported HK$0.033 earnings per share for the quarter, missing the consensus estimate of HK$0.087 by -HK$0.054.

Is Sino Biopharmaceutical Ltd overvalued?

According to Wall Street analysts Sino Biopharmaceutical Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Sino Biopharmaceutical Ltd pay dividends?

Sino Biopharmaceutical Ltd pays a Semiannually dividend of HK$0.314 which represents an annual dividend yield of 12.58%. See more information on Sino Biopharmaceutical Ltd dividends here

What is Sino Biopharmaceutical Ltd’s EPS estimate?

Sino Biopharmaceutical Ltd’s EPS estimate is 0.09.

How many shares outstanding does Sino Biopharmaceutical Ltd have?

Sino Biopharmaceutical Ltd has 18,760,717,000 shares outstanding.

What happened to Sino Biopharmaceutical Ltd’s price movement after its last earnings report?

Sino Biopharmaceutical Ltd reported an EPS of HK$0.033 in its last earnings report, missing expectations of HK$0.087. Following the earnings report the stock price went up 1.661%.

Which hedge fund is a major shareholder of Sino Biopharmaceutical Ltd?

Currently, no hedge funds are holding shares in HK:1177

Sino Biopharmaceutical Stock Smart Score

Outperform

Fundamentals

Return on Equity

6.14%

Trailing 12-Months

Asset Growth

-0.08%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Sino Biopharmaceutical Ltd

Sino Biopharmaceutical Limited (1177) is a leading pharmaceutical company based in China, specializing in the research, development, production, and sale of a wide range of biopharmaceutical products. The company focuses primarily on oncology, hepatitis, respiratory, and cardiovascular medicines, providing innovative and high-quality pharmaceutical solutions. By leveraging advanced technology and extensive research capabilities, Sino Biopharmaceutical aims to address significant medical needs and enhance the overall healthcare outcomes for patients globally.

1177 Stock 12 Month Forecast

Average Price Target

HK$6.04

▲(17.14%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"HK$1","8":"HK$8","2.75":"HK$2.75","4.5":"HK$4.5","6.25":"HK$6.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7.0000000035329,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$7.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.0444304921,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$6.04</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.10000000257397,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$5.10</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.75,4.5,6.25,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2023","6":"Apr<br/>2024","9":"Dec<br/>2024","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.368,4.5704615387333005,4.772923077466601,4.9753846161999,5.1778461549332,5.3803076936665,5.582769232399801,5.785230771133101,5.9876923098664,6.1901538485997,6.3926153873330005,6.5950769260663,6.797538464799601,{"y":7.0000000035329,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.368,4.496956191700001,4.6259123834,4.754868575100001,4.8838247668,5.0127809585000005,5.1417371502,5.2706933419,5.3996495336,5.5286057253,5.657561917,5.7865181087,5.9154743004,{"y":6.0444304921,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.368,4.42430769250569,4.48061538501138,4.53692307751707,4.59323077002276,4.64953846252845,4.70584615503414,4.76215384753983,4.81846154004552,4.87476923255121,4.9310769250569,4.98738461756259,5.0436923100682804,{"y":5.10000000257397,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.182,"date":1680307200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.418,"date":1690848000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.878,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.996,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.259,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.025,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.889,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.743,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.703,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.266,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.196,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.832,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.368,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >